Latest Regulatory News

New World Resources Limited has voluntarily suspended trading as it prepares to announce a significant change of control variation and a $10 million placement to advance its Antler Project in Arizona.

Javelin Minerals is fast-tracking mining at its Eureka Gold Project, targeting 34,000 recoverable ounces from a granted Mining Lease within 12 months. Advanced contractor talks and promising drilling results underpin this push in a buoyant gold price environment.

NeuroScientific Biopharmaceuticals reveals compelling clinical evidence supporting its StemSmart MSC therapy for severe steroid-refractory graft versus host disease, advancing its strategic acquisition plans.

Dalaroo Metals has launched its maiden exploration program at the Blue Lagoon project in Greenland, targeting zirconium, niobium, and rare earth elements. Led by seasoned geologist Ole Christiansen, the program aims to validate promising historical geochemical anomalies and assess low-cost mining potential.

Ioneer Ltd has issued 252.5 million new shares under a recent placement, complying fully with the Corporations Act while opting out of additional investor disclosures.

C29 Metals has secured Category 4 exploration approval for its newly granted eastern tenement in Kazakhstan, advancing its multi-mineral project and gaining strong local community support.

Meeka Metals has secured a $60 million institutional placement to fast-track gold production and expand drilling at its Murchison Gold Project in Western Australia, targeting first gold by June 2025.

Orthocell’s new study confirms Remplir™ delivers superior nerve regeneration and faster muscle recovery compared to traditional sutures, bolstering its US market rollout plans.

North Stawell Minerals has updated the timetable for its $3.6 million equity raising, delaying the placement settlement but maintaining the entitlement offer schedule.

Alkane Resources has secured Swedish regulatory approval for its proposed merger with Mandalay Resources, advancing a significant consolidation in the gold and antimony mining sector. The deal now awaits further approvals before shareholder votes expected in July.

EZZ Life Science has launched its US-focused brand EZZDAY with four FDA-registered supplements, marking a major step in its international growth strategy. The company has also begun US-based manufacturing and opened an online store to target American consumers.

Renergen Limited reports steady LNG production despite maintenance downtime, progresses a strategic merger with ASP Isotopes, and advances exploration with new seismic data and drilling activity.